Form 4 for JANX Janux Therapeutics, Inc.
Accepted 2026-05-13 20:00:09 ET · period of report 2026-05-11 · accession 0002032671-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-13 20:00 | 2026-05-11 | JANX | Dobek Maria | VP, Accounting | S - Sale | $14.17 | -2,038 | 32.3K | -6% | -$28.9K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-11 | S | D | 2,038 | $14.17 | 32,270 | D | — | — |